Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation

• Published in: Cell communication and signaling 2024-01, Vol.22 (1), p.48-13, Article 48
• Main Authors: Yu, Jae-Hyun, Choi, Myeung Gi, Lee, Na Young, Kwon, Ari, Lee, Euijin, Koo, Ja Hyun
• Format: Article
• Language: English
• Subjects: Antibodies; Antigens; Cell cycle; Cell growth; Cell interactions; Cell Transdifferentiation; Collagen (type I); Culture Media, Conditioned; Diet; Fibrosis; G protein-coupled receptors; Genes; Glucagon; Glucagon - metabolism; GPCR; Gαs; Hepatic stellate cell; Hepatic Stellate Cells; Hepatitis; Hepatocytes; Hepatocytes - metabolism; Humans; IL-33; Immune response; Immunoblotting; Innate immunity; Interferon regulatory factor; Interferon regulatory factor 3; Interferon Regulatory Factor-3 - metabolism; Interleukin-33 - metabolism; IRF3; Kinases; Liver; Liver cirrhosis; Liver Cirrhosis - metabolism; Phosphorylation; PKA; Plasmids; Protein expression; Protein kinase A; Proteins; Statistical analysis; Stellate cells
• ISSN: 1478-811X; 1478-811X
• DOI: 10.1186/s12964-023-01416-6

Interferon Regulatory Factor 3 (IRF3) is a transcription factor that plays a crucial role in the innate immune response by recognizing and responding to foreign antigens. Recently, its roles in sterile conditions are being studied, as in metabolic and fibrotic diseases. However, the search on the upstream regulator for efficient pharmacological targeting is yet to be fully explored. Here, we show that G protein-coupled receptors (GPCRs) can regulate IRF3 phosphorylation through of GPCR-Gα protein interaction. IRF3 and target genes were strongly associated with fibrosis markers in liver fibrosis patients and models. Conditioned media from MIHA hepatocytes overexpressing IRF3 induced fibrogenic activation of LX-2 hepatic stellate cells (HSCs). In an overexpression library screening using active mutant Gα subunits and Phos-tag immunoblotting, Gαs was found out to strongly phosphorylate IRF3. Stimulation of Gαs by glucagon or epinephrine or by Gαs-specific designed GPCR phosphorylated IRF3. Protein kinase A (PKA) signaling was primarily responsible for IRF3 phosphorylation and Interleukin 33 (IL-33) expression downstream of Gαs. PKA phosphorylated IRF3 on a previously unrecognized residue and did not require reported upstream kinases such as TANK-binding kinase 1 (TBK1). Activation of Gαs signaling by glucagon induced IL-33 production in hepatocytes. Conditioned media from the hepatocytes activated HSCs, as indicated by α-SMA and COL1A1 expression, and this was reversed by pre-treatment of the media with IL-33 neutralizing antibody. Gαs-coupled GPCR signaling increases IRF3 phosphorylation through cAMP-mediated activation of PKA. This leads to an increase of IL-33 expression, which further contributes to HSC activation. Our findings that hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation provides an insight for understanding the complex intercellular communication during liver fibrosis progression and suggests therapeutic opportunities for the disease. Video Abstract.